One of the recent IPO's that we'd like to buy at a cheaper price is IVF provider Monash IVF
Independent Financial Research
One of the recent IPO's that we'd like to buy at a cheaper price is IVF provider Monash IVF. There's an almighty tailwind blowing behind fertility treatments, as more and more older and richer women need help to fall pregnant. Monash IVF is the smaller rival of Virtus Health, which listed last year. It now sports a price about 40% above its issue price of $5.68 and is acquiring similar businesses abroad. We expect Monash IVF will use the same playbook if it's not acquired by Virtus beforehand. Monash IVF is another fast growing company with a solid market position - we would consider upgrading the stock below $1.70. We also discuss Ozforex and our view on IPO's on our Blog. (VIEW LINK)
Intelligent Investor is an independent financial research service with a 14-year history of beating the market. Our value investing approach empowers Australians to make more informed decisions to build their long-term wealth. We off structural...
Expertise
No areas of expertise
Intelligent Investor is an independent financial research service with a 14-year history of beating the market. Our value investing approach empowers Australians to make more informed decisions to build their long-term wealth. We off structural...
Expertise
No areas of expertise